Ojemda Kit
Product Images NDC 82950-012

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Ojemda (NDC 82950-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Day One Biopharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ojemda 01)

Chemical structure of tovorafenib shown as a molecular diagram with various rings and functional groups, including chloro, trifluoromethyl, and amide moieties, representing the active ingredient in OJEMDA 100 mg kit by Day One Biopharmaceuticals, Inc.*

FDA Label Image

Figure (Ojemda 02)

An illustration showing three components of the OJEMDA kit by Day One Biopharmaceuticals, Inc.: a bottle with a cap, a bottle adaptor, and a 20 mL oral dosing syringe labeled with plunger, barrel, and tip parts.*

FDA Label Image

Figure (Ojemda 03)

An illustration showing a cup half-filled with liquid at room temperature, indicated by a label stating "Room Temperature." A line crosses horizontally through the cup to indicate the liquid level.*

FDA Label Image

Figure (Ojemda 04)

An instructional illustration in two panels showing hands manipulating a syringe. The left panel depicts a hand pulling the plunger of the syringe upward, while the right panel shows a hand pushing the plunger downward, indicating steps likely related to syringe preparation or use.*

FDA Label Image

Figure (Ojemda 05)

An instructional illustration showing a person pulling a syringe-like device upward from a cup of liquid. A close-up inset highlights a 14 mL liquid level marked on the graduated syringe.*

FDA Label Image

Figure (Ojemda 06)

An instructional illustration showing three syringes with liquid levels. The first two syringes are labeled "Not okay" with an "X" mark, indicating incorrect fill levels, while the third syringe is labeled "Okay" with a check mark, indicating the correct fill level. The syringes are marked with measurements up to 25 units, highlighting proper dosage measurement.*

FDA Label Image

Figure (Ojemda 07)

An instructional illustration showing hands opening a bottle with a safety seal. The left panel demonstrates twisting the cap to open, while the right panel highlights the removal of the safety seal from the bottle neck.*

FDA Label Image

Figure (Ojemda 08)

An instructional three-panel illustration showing steps to prepare a medication kit. The first panel depicts drawing liquid into a syringe attached to a vial. The second panel shows twisting a cap onto the vial. The third panel illustrates shaking the vial with arrows indicating movement, accompanied by a timer icon indicating 60 seconds.*

FDA Label Image

Figure (Ojemda 09)

Instructional illustration showing a person holding a small bottle at eye level. The image compares incorrect and correct ways to hold the bottle, indicating the correct method is to hold it upright with the cap facing down and to look directly at it.*

FDA Label Image

Figure (Ojemda 10)

Instructional illustration for OJEMDA kit showing two steps: first, the user shaking a small vial for 30 seconds, indicated by a circular arrow and a timer icon; second, allowing a bottle to sit for 60 seconds, with a caution symbol and timer icon. The illustrations focus on the preparation process for the product.*

FDA Label Image

Figure (Ojemda 11)

An instructional illustration showing a hand removing or placing a cap on a bottle. The diagram highlights the steps for handling the bottle cap, indicating pressing down and twisting motions.*

FDA Label Image

Figure (Ojemda 12)

An instructional illustration showing a hand holding a syringe with a plunger, positioned above an extended finger of the other hand. An arrow indicates a downward motion, suggesting injection or drawing up from the finger.*

FDA Label Image

Figure (Ojemda 13)

Instructional illustration showing the preparation steps for OJEMDA 100 mg/1 kit. The first image depicts a hand drawing medication into a syringe from a vial. The second image shows a hand holding a vial being gently rotated, with a 30-second timer icon indicating the mixing or reconstitution time.*

FDA Label Image

Figure (Ojemda 14)

Instructional illustration showing two steps: first, a hand pressing down a syringe plunger into a vial; second, a hand drawing liquid from the vial into the syringe. The images depict proper preparation technique for drug administration.*

FDA Label Image

Figure (Ojemda 15)

An instructional illustration showing how to use a syringe with a cap or protective cover. The sequence depicts removing the cap from the syringe and then holding the syringe upright, potentially preparing for medication administration or drawing liquid into the syringe.*

FDA Label Image

Figure (Ojemda 16)

An instructional illustration showing a hand holding a vial with the other hand removing a syringe from the vial by pulling it upward. This image likely demonstrates the proper technique for withdrawing medication from a vial using a syringe.*

FDA Label Image

Figure (Ojemda 17)

An instructional illustration showing a person using an oral syringe to administer medication into their mouth. The syringe is held by hand and positioned at the mouth opening for dosage delivery.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for OJEMDA (tovorafenib) oral suspension kit, 25 mg/mL strength, made by Day One Biopharmaceuticals, Inc. The label notes the product is for prescription use only and contains one bottle of oral suspension, one oral dosing syringe, one bottle adapter, and instructions for use. It also provides dosage and administration instructions and storage conditions.*

FDA Label Image

Principal Display Panel (100 mg Tablet Blister Pack Carton)

Packaging label for OJEMDA (tovorafenib) tablets 100 mg by Day One Biopharmaceuticals, Inc. The kit contains 16 oral tablets. The label includes dosage instructions, storage conditions (20 to 25°C with permitted excursions), and manufacturer information. The design features a white background with orange and yellow accents and a barcode on one panel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.